Publications by authors named "Helmut Deissler"

Claim this Profile
N
Novel Needle for Intravitreal Injections Does Not Affect Biological Activity of Anti-VEGF Drugs.
Lyubomyr Lytvynchuk, Kai L Nolte, Isabell Fuezy, Wen Zhou, Helmut Deissler, Heidrun L Deissler

Clin Ophthalmol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sitagliptin does not interfere with VEGF-A signaling in retinal endothelial cells in vitro.
Lucian Amthor, Anja Jaeckle, Juergen Kampmeier, Armin Wolf, Matus Rehak, Helmut Deissler, Heidrun L Deissler

Exp Clin Endocrinol Diabetes· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
pH-dependent vs. constant release of mesalazine in the treatment of ulcerative colitis: Do drug delivery concepts determine therapeutic efficacy? (Review).
Helmut Deissler, Heinrich Krammer, Anton Gillessen

Biomed Rep· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sitagliptin and the Blood-Retina Barrier: Effects on Retinal Endothelial Cells Manifested Only after Prolonged Exposure.
Anja Jäckle, Focke Ziemssen, Eva-Maria Kuhn, Jürgen Kampmeier, Gerhard K Lang, Helmut Deissler, Heidrun L Deissler

J Diabetes Res· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A low-frequency haplotype spanning SLX4/FANCP constitutes a new risk locus for early-onset breast cancer (<60 years) and is associated with reduced DNA repair capacity.
Harald Surowy, Dominic Varga, Barbara Burwinkel, Frederik Marmé, Christof Sohn, Helmut Deissler

Int J Cancer· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety of monoclonal antibodies and related therapeutic proteins for the treatment of neovascular macular degeneration: addressing outstanding issues.
Focke Ziemssen, Bianka Sobolewska, Heidrun Deissler, Helmut Deissler

Expert Opin Drug Saf· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Ranibizumab efficiently blocks migration but not proliferation induced by growth factor combinations including VEGF in retinal endothelial cells.
Heidrun L Deissler, Helmut Deissler, Gerhard K Lang, Gabriele E Lang

Graefes Arch Clin Exp Ophthalmol· October 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
VEGF but not PlGF disturbs the barrier of retinal endothelial cells.
Heidrun L Deissler, Helmut Deissler, Gerhard K Lang, Gabriele E Lang

Exp Eye Res· October 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of alternative transcripts of rat CD9 expressed by tumorigenic neural cell lines and in normal tissues.
Sonja Wolfahrt, Sandra Herman, Claus-Jürgen Scholz, Georg Sauer, Helmut Deissler

Genet Mol Biol· July 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genome-wide association study in BRCA1 mutation carriers identifies novel loci associated with breast and ovarian cancer risk.
Fergus J Couch, Xianshu Wang, Lesley McGuffog, Andrew Lee, Curtis Olswold, Helmut Deissler

PLoS Genet· June 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer.
Stig E Bojesen, Karen A Pooley, Sharon E Johnatty, Jonathan Beesley, Kyriaki Michailidou, Helmut Deissler

Nat Genet· April 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A nonsynonymous polymorphism in IRS1 modifies risk of developing breast and ovarian cancers in BRCA1 and ovarian cancer in BRCA2 mutation carriers.
Yuan C Ding, Lesley McGuffog, Sue Healey, Eitan Friedman, Yael Laitman, Helmut Deissler

Cancer Epidemiol Biomarkers Prev· August 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Actions of bevacizumab and ranibizumab on microvascular retinal endothelial cells: similarities and differences.
Heidrun L Deissler, Helmut Deissler, Gabriele E Lang

Br J Ophthalmol· July 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Common breast cancer susceptibility alleles are associated with tumour subtypes in BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1/2.
Anna Marie Mulligan, Fergus J Couch, Daniel Barrowdale, Susan M Domchek, Diana Eccles, Helmut Deissler

Breast Cancer Res· June 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Ovarian cancer susceptibility alleles and risk of ovarian cancer in BRCA1 and BRCA2 mutation carriers.
Susan J Ramus, Antonis C Antoniou, Karoline B Kuchenbaecker, Penny Soucy, Jonathan Beesley, Helmut Deissler

Hum Mutat· April 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Common variants at the 19p13.1 and ZNF365 loci are associated with ER subtypes of breast cancer and ovarian cancer risk in BRCA1 and BRCA2 mutation carriers.
Fergus J Couch, Mia M Gaudet, Antonis C Antoniou, Susan J Ramus, Karoline B Kuchenbaecker, Helmut Deissler

Cancer Epidemiol Biomarkers Prev· April 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association of death receptor 4 variant (683A > C) with ovarian cancer risk in BRCA1 mutation carriers.
Michelle G Dick, Beatrix Versmold, Christoph Engel, Alfons Meindl, Norbert Arnold, Helmut Deissler

Int J Cancer· March 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Common variants at 12p11, 12q24, 9p21, 9q31.2 and in ZNF365 are associated with breast cancer risk for BRCA1 and/or BRCA2 mutation carriers.
Antonis C Antoniou, Karoline B Kuchenbaecker, Penny Soucy, Jonathan Beesley, Xiaoqing Chen, Helmut Deissler

Breast Cancer Res· February 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pathology of breast and ovarian cancers among BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA).
Nasim Mavaddat, Daniel Barrowdale, Irene L Andrulis, Susan M Domchek, Diana Eccles, Helmut Deissler

Cancer Epidemiol Biomarkers Prev· January 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Medium-sized deletion in the BRCA1 gene: Limitations of Sanger sequencing and MLPA analyses.
Sandra Herman, Dominic Varga, Heidrun L Deissler, Rolf Kreienberg, Helmut Deissler

Genet Mol Biol· January 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Haplotype structure in Ashkenazi Jewish BRCA1 and BRCA2 mutation carriers.
Kate M Im, Tomas Kirchhoff, Xianshu Wang, Todd Green, Clement Y Chow, Helmut Deissler

Hum Genet· November 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Interplay between BRCA1 and RHAMM regulates epithelial apicobasal polarization and may influence risk of breast cancer.
Christopher A Maxwell, Javier Benítez, Laia Gómez-Baldó, Ana Osorio, Núria Bonifaci, Helmut Deissler

PLoS Biol· November 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular indicators of non-sentinel node status in breast cancer determined in preoperative biopsies by multiplexed sandwich immunoassays.
Georg Sauer, Nicole Schneiderhan-Marra, Rainer Muche, Karin Koretz, Cornelia Kazmaier, Helmut Deissler

J Cancer Res Clin Oncol· August 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Common alleles at 6q25.1 and 1p11.2 are associated with breast cancer risk for BRCA1 and BRCA2 mutation carriers.
Antonis C Antoniou, Christiana Kartsonaki, Olga M Sinilnikova, Penny Soucy, Lesley McGuffog, Helmut Deissler

Hum Mol Genet· August 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Germline mutations in the PALB2 gene are population specific and occur with low frequencies in familial breast cancer.
Heide Hellebrand, Christian Sutter, Ellen Honisch, Eva Gross, Barbara Wappenschmidt, Helmut Deissler

Hum Mutat· June 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis